NYSE:MED - US58470H1014 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | 3.64M | 2.09M | 99.42M | 143.60M | 164.00M | |||
Depreciation Amortization | 13.70M | 12.71M | 13.11M | 11.00M | 6.80M | |||
Income Taxes - Deferred | -7.41M | -7.40M | 1.21M | -900.00K | -3.70M | |||
Change In Working Capital | -16.30M | -9.74M | 20.28M | 21.70M | -87.60M | |||
Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
Taxes Paid | 8.22M | 1.62M | 34.26M | -37.20M | 56.80M | |||
Other non cash items | 10.52M | 26.83M | 13.65M | 19.30M | 15.10M | |||
OPERATING CASH FLOW | 4.15M | 24.48M | 147.66M | 194.60M | 94.50M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -6.58M | -7.45M | -6.48M | -16.70M | -34.20M | |||
Other Investing Activity | -3.33M | -19.07M | -54.56M | 5.30M | 5.10M | |||
INVESTING CASH FLOW | -9.91M | -26.52M | -61.05M | -11.40M | -29.10M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
Stock Issued/Repurchased | 0.00 | 36.00K | -3.41M | -126.40M | -55.20M | |||
Dividend Paid | -196.00K | -715.00K | -73.02M | -71.60M | -63.90M | |||
Other Financing Activity | -373.00K | -836.00K | -3.36M | -1.50M | -6.10M | |||
FINANCING CASH FLOW | -569.00K | -1.51M | -79.79M | -199.60M | -125.10M | |||
Exchange Rate Effect | 4.00K | 47.00K | -72.00K | -100.00K | 100.00K | |||
CHANGE IN CASH | -6.32M | -3.51M | 6.75M | -16.50M | -59.60M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | 4.15M | 24.48M | 147.66M | 194.60M | 94.50M | |||
Capital Expenditure | -6.58M | -7.45M | -6.48M | -16.70M | -34.20M | |||
FREE CASH FLOW | -2.42M | 17.02M | 141.17M | 177.90M | 60.30M |
All data in USD